1. [DNA immunization with a plasmid containing gene of hepatitis C virus protein 5A (NS5A) induces the effective cellular immune response].
- Author
-
Masalova OV, Lesnova EI, Grabovetskiĭ VV, Smirnova OA, Ulanova TI, Burkov AN, Ivanov AV, Zaberezhnyĭ AD, Ataullakhanov RI, and Kushch AA
- Subjects
- Animals, Cell Line, Tumor, Cell Proliferation, Chlorocebus aethiops, Female, Hepacivirus genetics, Hepacivirus metabolism, Hepatitis C genetics, Hepatitis C metabolism, Hepatitis C prevention & control, Humans, Immunity, Cellular, Interferon-gamma biosynthesis, Interferon-gamma immunology, Interleukin-2 biosynthesis, Interleukin-2 immunology, Mice, Plasmids genetics, Plasmids immunology, Plasmids metabolism, T-Lymphocytes metabolism, Vaccines, DNA genetics, Vaccines, DNA immunology, Vaccines, DNA metabolism, Vero Cells, Viral Hepatitis Vaccines genetics, Viral Hepatitis Vaccines immunology, Viral Hepatitis Vaccines metabolism, Viral Nonstructural Proteins biosynthesis, Viral Nonstructural Proteins genetics, Hepacivirus immunology, Hepatitis C immunology, Plasmids pharmacology, T-Lymphocytes immunology, Vaccines, DNA pharmacology, Viral Hepatitis Vaccines pharmacology, Viral Nonstructural Proteins immunology
- Abstract
In spite of extensive research, no effective vaccine against hepatitis C virus (HCV) has been developed so far. DNA immunization is a potent technique of vaccine design strongly promoting the cellular arm of immune response. The genes encoding nonstructural HCV proteins (NS2-NS5B) are promising candidates for vaccine development. NS5A is a protein involved in viral pathogenesis, in the induction of immune response, and probably in viral resistance to interferon treatment. The objective of this study was to construct a DNA vaccine encoding NS5A protein and evaluate its immunogenicity. A plasmid encoding a full-size NS5A protein was produced using the pcDNA3.1 (+) vector for eukaryotic expression system. The expression of the NS5A gene was confirmed by immunoperoxidase staining of the transfected eukaryotic cells with anti-NS5A monoclonal antibodies. Triple immunization of mice with the plasmid vaccine induced a pronounced cellular immune response against abroad spectrum of NSSA epitopes as assessed by T-cell proliferation andsecretion of antiviral cytokines IFN-gamma and IL-2. In in vitro T-cell stimulation experiments, NS5A-derived antigens were modeled by synthetic peptides, recombinant proteins of various genotypes, and phages carrying exposed NS5A peptides. A novel immunomodulator Immunomax showed high adjuvant activity in DNA immunization. The data obtained indicate that the suggested DNA construct has a strong potential in the development of the gene vaccines against hepatitis C.
- Published
- 2010